On April 4, 2016, CMS released its 2017 Final Call Letter. CMS acknowledged AMCP in the 2017 Final Call Letter and credits the important work that AMCP’s Medication Therapy Management Advisory Group is doing to develop a framework to define drug therapy problems. Additionally, CMS altered its timeline for removing the high-risk medication (HRM) measure from the Star Ratings from 2017 to 2018.
AMCP summary of the CMS 2017 Draft Call Letter.
AMCP Summary: Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter
CMS CY 2016 Formulary Information
CMS December 2015 Memorandum on Part D Transition Monitoring Program
Centers for Medicare and Medicaid Services (CMS) is issuing this memorandum to provide clarifying guidance to Medicare Part D plan sponsors concerning the Part D program’s any willing pharmacy (AWP) requirement.
CY 2016 Medication Therapy Management Program Guidance and Submission Instructions
On February 20, 2015, CMS released its 2016 Part D Call Letter in a notice to Medicare Advantage organizations and Prescription Drug Plan sponsors.
Presentation developed in February 2015.
Presentation developed in February 2015.
